Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

825 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial.
Ferdinand KC, Clark LT, Watson KE, Neal RC, Brown CD, Kong BW, Barnes BO, Cox WR, Zieve FJ, Isaacsohn J, Ycas J, Sager PT, Gold A; ARIES Study Group. Ferdinand KC, et al. Among authors: gold a. Am J Cardiol. 2006 Jan 15;97(2):229-35. doi: 10.1016/j.amjcard.2005.08.026. Epub 2005 Nov 28. Am J Cardiol. 2006. PMID: 16442368 Clinical Trial.
Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Jones PH, et al. Among authors: gold a. Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006. Clin Ther. 2004. PMID: 15531001 Clinical Trial.
Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
Roth EM, McKenney JM, Kelly MT, Setze CM, Carlson DM, Gold A, Stolzenbach JC, Williams LA, Jones PH. Roth EM, et al. Among authors: gold a. Am J Cardiovasc Drugs. 2010;10(3):175-86. doi: 10.2165/11533430-000000000-00000. Am J Cardiovasc Drugs. 2010. PMID: 20524719 Clinical Trial.
The stain wars.
Olsson GO, Blasetto JW, Bryzinski BS, Caplan RJ, Gold A. Olsson GO, et al. Among authors: gold a. Lancet. 2003 Nov 29;362(9398):1855-6; discussion 1856. doi: 10.1016/s0140-6736(03)14934-3. Lancet. 2003. PMID: 14654329 No abstract available.
Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study.
Reilly-Harrington NA, Sylvia LG, Rabideau DJ, Gold AK, Deckersbach T, Bowden CL, Bobo WV, Singh V, Calabrese JR, Shelton RC, Friedman ES, Thase ME, Kamali M, Tohen M, McInnis MG, McElroy SL, Ketter TA, Kocsis JH, Kinrys G, Nierenberg AA. Reilly-Harrington NA, et al. Among authors: gold ak. J Affect Disord. 2016 Nov 15;205:159-164. doi: 10.1016/j.jad.2016.07.007. Epub 2016 Jul 5. J Affect Disord. 2016. PMID: 27449548 Clinical Trial.
Comorbid anxiety in bipolar CHOICE: Insights from the bipolar inventory of symptoms scale.
Kinrys G, Bowden CL, Nierenberg AA, Hearing CM, Gold AK, Rabideau DJ, Sylvia LG, Gao K, Kamali M, Bobo WV, Tohen M, Deckersbach T, McElroy SL, Ketter TA, Shelton RC, Friedman ES, Calabrese JR, McInnis MG, Kocsis J, Thase ME, Singh V, Reilly-Harrington NA. Kinrys G, et al. Among authors: gold ak. J Affect Disord. 2019 Mar 1;246:126-131. doi: 10.1016/j.jad.2018.12.039. Epub 2018 Dec 18. J Affect Disord. 2019. PMID: 30580198 Clinical Trial.
825 results